Tinea Cruris Clinical Trial
Official title:
A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Product 33525 in Subjects With Tinea Cruris
To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00750152 -
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
|
Phase 3 | |
| Completed |
NCT01712360 -
Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis
|
Phase 4 | |
| Not yet recruiting |
NCT05881980 -
Efficacy and Safety of Terbinafine and Itraconazole
|
Phase 2/Phase 3 | |
| Completed |
NCT01349998 -
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
|
Phase 3 | |
| Completed |
NCT03359070 -
Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris
|
Phase 2 | |
| Completed |
NCT02394340 -
Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris
|
Phase 4 | |
| Completed |
NCT05363449 -
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
|
Phase 1 | |
| Completed |
NCT02767271 -
Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris
|
Phase 4 | |
| Completed |
NCT01885156 -
Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris
|
Phase 3 | |
| Not yet recruiting |
NCT01105013 -
Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections
|
Phase 3 |